Celesio AG buy matumba
Summary
This prediction ended on 07.02.11 with a price of €18.67. The BUY prediction by matumba finished with a performance of 4.07%. matumba has 50% into this predictionCelesio is a listed healthcare company that provides wholesale, delivery, and retail distribution services for pharmaceutical and healthcare products in Europe. The company operates through its three segments: Prescription Retail, Pharmacy Wholesale, and Consumer Solutions, and its services cater to individual customers, hospitals, and healthcare professionals. Celesio also offers digital healthcare solutions and operates pharmacies across Europe. As of July 2021, Celesio's stock is trading at approximately €25 per share on the Frankfurt Stock Exchange.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celesio AG | - | - | - | - |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% | 16.867% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% | 45.898% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% | 2.760% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% | 42.955% |
Comments by matumba for this prediction
In the thread Celesio AG diskutieren
die wende ?
das Kursziel von bürse online spielte mit 27,00 Euro noch mit dem verkauf von ratiopharm,
da nun die marktanteile wiedererlangt und die apotheker ruhiger sind halte ich eine wende für wahrscheinlich.
falls die Marke nicht unter 17,50 fällt, und ein deutliches Zeichen die Trendwende einläutet, schlag ich zu